![]() OrphoMed OrphoMed is a clinical-stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. | ![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 1904 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 10 | Employees 3,0015% increase | Employees 7,5692% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Operating ⚠ | |||
Patent Applications | Patent Applications N/A | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) |

BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company